Special Issue "Fatty Liver Disease: Diagnostic, Predictive and Prognostic Markers"
Deadline for manuscript submissions: 31 May 2021.
Interests: Fibrosis; Lipids
Fatty liver disease (FLD) is generally considered as the hepatic manifestation of metabolic syndrome and it is associated with a high prevalence of advanced fibrosis, hepatocellular carcinoma (HCC), and atherosclerotic diseases including cardiovascular disease. FLD includes steatosis, hepatic inflammation, hepatocellular ballooning, as well as liver fibrosis, which are diagnosed and evaluated by analyzing a liver biopsy. However, because the procedure to obtain liver biopsies has several disadvantages, such as a high cost and associated complications, alternatives to biopsy analysis are required. This Special Issue will include papers that investigate new biomarkers or imaging techniques to diagnose the presence of steatohepatitis, the severity of liver fibrosis, FLD-associated HCC, and extrahepatic complications including atherosclerosis and to identify predictive factors of FLD. Additionally, clinical studies examining potential new genetic biomarkers for FLD are welcome. This Special Issue will publish original research and review papers.
Dr. Kento Imajo
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Fatty liver disease
- Nonalcoholic fatty liver disease
- Nonalcoholic steatohepatitis
- Hepatic inflammation